Akathisia and abnormal movements of the upper extremities with venlafaxine and methimazole

General Hospital Psychiatry

Volumn 31, Issue 4, 2009, Pages 388-390

  Ng, Jean ^a   Sansone, Randy A ^a,b   McDonald, Stephen ^a,b  

^a KETTERING MEDICAL CENTER   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMLODIPINE; BISOPROLOL; CLOPIDOGREL; ERYTHROMYCIN; FLUTICASONE; GLIPIZIDE; LANSOPRAZOLE; MONTELUKAST; PENICILLIN G; PREDNISONE; SULFANILAMIDE DERIVATIVE; THIAMAZOLE; VENLAFAXINE;

ADULT; AKATHISIA; ANAMNESIS; ARM MOVEMENT; ARTICLE; BACKACHE; CASE REPORT; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FAMILY HISTORY; FEMALE; FOLLOW UP; GRAVES DISEASE; HUMAN; HYPERTENSION; HYPERTHYROIDISM; LUNG FIBROSIS; MAJOR DEPRESSION; MOTOR DYSFUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESCRIPTION;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTITHYROID AGENTS; ARM; CAUSALITY; CYCLOHEXANOLS; CYTOCHROME P-450 CYP2D6; DEPRESSIVE DISORDER, MAJOR; DRUG INTERACTIONS; DYSKINESIAS; FEMALE; HUMANS; HYPERTHYROIDISM; METABOLIC CLEARANCE RATE; METHIMAZOLE; MIDDLE AGED; PSYCHOMOTOR AGITATION; RECEPTORS, DOPAMINE; SEROTONIN UPTAKE INHIBITORS;

EID: 67449104701     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2008.10.001     Document Type: Article

References (9)

1. Breggin P.R. Recent regulatory changes in antidepressant labels: implications of activation (stimulation) for clinical practice. Prim Psychiatry 13 (2006) 57-60
2. Sekine Y., Suzuki K., Ramachandran P.V., Blackburn T.P., and Ashby C.R. Acute and repeated administration of fluoxetine, citalopram, and paroxetine significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study. Synapse 61 (2007) 72-77
3. Hansen L. A critical review of akathisia, and its possible association with suicidal behaviour. Hum Psychopharmacol 16 (2001) 495-505
4. Garcia-Parajua P., Alvarez Iniesta I., and Magarinos M. Reversible and dose-related parkinsonism induced by venlafaxine. Med Clin (Barc) 120 (2003) 759
5. Lee Y., Yeh W.C., Chong M.Y., Lin P.Y., and Chang Y.Y. Venlafaxine and tardive blepharospasm: a case report. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 1139-1140
6. Lu T.C., Chu P.L., Wu C.S., Tsai K.C., and Chen W.J. Neuroleptic malignant syndrome after the use of venlafaxine in a patient with generalized anxiety disorder. J Formos Med Assoc 105 (2006) 90-93
7. Crocker A.D., Overstreet D.H., and Crocker J.M. Hypothyroidism leads to increased dopamine receptor sensitivity and concentration. Pharmacol Biochem Behav 24 (1986) 1593-1597
8. Cameron D.L., and Crocker A.D. The hypothyroid rat as a model of increased sensitivity to dopamine receptor agonists. Pharmacol Biochem Behav 37 (1990) 627-632
9. Author. Clinical pharmacology (2008), Gold Standard, Tampa (FL)